Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW -- Ignore unavailable to you. Want to Upgrade?

To: Gerald Underwood who wrote (44)	11/13/1997 3:01:00 PM
From: MarcG	Read Replies (1) \| Respond to of 857

Gerry, I guess you're referring to NEWS today about expansion of management, not the 10Q. IMO, the combination of both at the same time is very positive. Add to that what I told you about the west coast roadshow beginning the 19th and possible brokerage sponsorships, that's a barrage of NEWS. I'm very impressed with the appointment of Mr. Kidd. Columbia Labs and CarePlus, where he held previous positions, are both extremely successful, especially concerning the increase to long term shareholder values. His reach to the European arena bodes very well. The addition of $10 M to HEB's coffers was timed excellently. Other items I noticed in the 10Q; Didn't the Amp-516 expand by 6 more patients to 26? 4 new patents were accepted in New Zealand. There seems to be a concentrated effort to move on Hepatitis-B (HBV). The merits of AIDS "cocktails" are mentioned. Finally, I liked the numbers. HEB at this time is about the #3 gainer on the AMEX today, and may get more exposure overnight on NBR. Out of the 3 gainers, HEB is the only one with NEWS. MG: